Brii Biosciences Limited , a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced new...
Antengene Corporation Limited, a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life-threatening...
IASO Biotherapeutics, a clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing innovative medicines and Innovent Biologics, Inc., a world-class biopharmaceutical company that develops,...
PharmaMar and partner Jazz Pharmaceuticals plc announced the initiation of a confirmatory Phase 3 clinical trial, LAGOON, evaluating Zepzelca® (lurbinectedin) for the treatment of...
Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, announced that it has strengthened its support to a near-majority holding...
